Baidu
map

风湿免疫指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫指南

2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理

2021-08-01 荷兰皇家物理治疗学会 Phys Ther

类风湿关节炎

2021年8月，荷兰皇家物理治疗学会(KNGF)发布了类风湿性关节炎患者的物理治疗管理指南。本文是对2008年类风湿性关节炎患者的物理治疗指南的更新。

中文标题：

2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理

英文标题：

Clinical Practice Guideline for Physical Therapist Management of People With Rheumatoid Arthritis

发布机构：

荷兰皇家物理治疗学会

发布日期：

2021-08-01

简要介绍：

2021年8月，荷兰皇家物理治疗学会(KNGF)发布了类风湿性关节炎患者的物理治疗管理指南。本文是对2008年类风湿性关节炎患者的物理治疗指南的更新。主要针对类风湿性关节炎患者的评估和治疗提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9b4b61c0022e25ea, title=2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理, enTitle=Clinical Practice Guideline for Physical Therapist Management of People With Rheumatoid Arthritis, guiderFrom=Phys Ther, authorId=0, author=, summary=2021年8月，荷兰皇家物理治疗学会(KNGF)发布了类风湿性关节炎患者的物理治疗管理指南。本文是对2008年类风湿性关节炎患者的物理治疗指南的更新。, cover=https://img.medsci.cn/20211126/1637936453009_1608702.jpg, journalId=0, articlesId=null, associationId=1244, associationName=荷兰皇家物理治疗学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，荷兰皇家物理治疗学会(KNGF)发布了类风湿性关节炎患者的物理治疗管理指南。本文是对2008年类风湿性关节炎患者的物理治疗指南的更新。主要针对类风湿性关节炎患者的评估和治疗提供指导建议。</span></p>, tagList=[TagDto(tagId=457, tagName=类风湿关节炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=457, guiderKeyword=类风湿关节炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2110, appHits=201, showAppHits=0, pcHits=532, showPcHits=1909, likes=1, shares=18, comments=4, approvalStatus=1, publishedTime=Sun Nov 28 13:46:49 CST 2021, publishedTimeString=2021-08-01, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Nov 26 22:25:00 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 12:50:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理.pdf)])
2021 KNGF临床实践指南：类风湿性关节炎患者的物理治疗管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190636, encodeId=59741190636a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf64678989, createdName=2942656268, createdTime=Mon Feb 07 01:09:19 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079355, encodeId=860810e93556b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:53:47 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078293, encodeId=951710e8293c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Thu Dec 09 07:07:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074943, encodeId=972710e494323, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:54 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2022-02-07 2942656268

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190636, encodeId=59741190636a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf64678989, createdName=2942656268, createdTime=Mon Feb 07 01:09:19 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079355, encodeId=860810e93556b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:53:47 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078293, encodeId=951710e8293c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Thu Dec 09 07:07:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074943, encodeId=972710e494323, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:54 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-12-12 ms8000001575079939

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190636, encodeId=59741190636a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf64678989, createdName=2942656268, createdTime=Mon Feb 07 01:09:19 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079355, encodeId=860810e93556b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:53:47 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078293, encodeId=951710e8293c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Thu Dec 09 07:07:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074943, encodeId=972710e494323, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:54 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-12-09 Svana

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190636, encodeId=59741190636a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf64678989, createdName=2942656268, createdTime=Mon Feb 07 01:09:19 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079355, encodeId=860810e93556b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:53:47 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078293, encodeId=951710e8293c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Thu Dec 09 07:07:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074943, encodeId=972710e494323, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:58:54 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-11-29 微探

    学习学习

    0

相关指南

2021 药师共识指南：类风湿关节炎患者生物制剂过渡的监测

国外药师专家小组（统称） · 2021-09-14

类风湿关节炎相关自身抗体检测的临床应用专家共识

中国医师协会风湿免疫科医师分会 · 2021-06-17

2021 ACR指南：类风湿关节炎的治疗

美国风湿病学会(ACR,American College of Rheumatology) · 2021-06-08

类风湿关节炎中西医结合医疗质量控制指标专家共识（2021年版）

暂未更新 · 2021-02-20

雷公藤多苷/雷公藤片治疗类风湿关节炎的临床实践指南 2021

暂未更新 · 2021-01-14

锝[99Tc]亚甲基二膦酸盐注射液治疗类风湿关节炎专家共识

国家风湿病数据中心 · 2019-10-30

拓展阅读

2010 BSR/BHPR 类风湿关节炎中抗肿瘤坏死因子疗法的安全指引

英国风湿病学会(BSR,British Society for Rheumatology) · 2010-01-01

2010版类风湿关节炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-04-01

2010 依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议

中国风湿免疫科相关专家小组（统称） · 2010-06-30

2010 ACR/EULAR 类风湿关节炎分类标准

美国风湿病学会(ACR,American College of Rheumatology) · 2010-09-01

2011 BSR/BHPR 指南：使用利妥昔单抗治疗类风湿关节炎

英国风湿病学会(BSR,British Society for Rheumatology) · 2011-01-01

2011SIGN 苏格兰国家类风湿关节炎早期治疗临床指南

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2011-01-01

Baidu
map
Baidu
map
Baidu
map